139 related articles for article (PubMed ID: 33939317)
1. RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome.
Romanisio G; Chelleri C; Scala M; Piccolo G; Carlini B; Gatti L; Capra V; Zara F; Bersano A; Pavanello M; De Marco P; Diana MC
Mol Genet Genomic Med; 2021 Jun; 9(6):e1669. PubMed ID: 33939317
[No Abstract] [Full Text] [Related]
2. Moyamoya syndrome in a child with Legius syndrome: Introducing a cerebral vasculopathy to the SPRED1 phenotype?
Pabst L; Carroll J; Lo W; Truxal KV
Am J Med Genet A; 2021 Jan; 185(1):223-227. PubMed ID: 33078527
[TBL] [Abstract][Full Text] [Related]
3. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
4. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
[TBL] [Abstract][Full Text] [Related]
5. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
6. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
[TBL] [Abstract][Full Text] [Related]
7. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor: RNF213 variant and quasimoyamoya disease.
Komiyama M
J Neurosurg Pediatr; 2016 Nov; 18(5):653-654. PubMed ID: 27494443
[No Abstract] [Full Text] [Related]
9. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.
Kim WH; Kim SD; Nam MH; Jung JM; Jin SW; Ha SK; Lim DJ; Lee HB
Childs Nerv Syst; 2019 Feb; 35(2):309-314. PubMed ID: 30283986
[TBL] [Abstract][Full Text] [Related]
10. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
[TBL] [Abstract][Full Text] [Related]
11. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
[TBL] [Abstract][Full Text] [Related]
12. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
13. A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213.
Strong A; O'Grady G; Shih E; Bishop JR; Loomes K; Diamond T; Hartung EA; Wong W; Cuddapah S; Cahill AM; Hou C; Slater D; Vaccaro C; Watson D; Li D; Hakonarson H
Am J Med Genet A; 2021 Jul; 185(7):2168-2174. PubMed ID: 33960657
[TBL] [Abstract][Full Text] [Related]
14. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
15. Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.
Mineharu Y; Takagi Y; Takahashi JC; Hashikata H; Liu W; Hitomi T; Kobayashi H; Koizumi A; Miyamoto S
Cerebrovasc Dis; 2013; 36(2):155-7. PubMed ID: 24029639
[No Abstract] [Full Text] [Related]
16. Surgical Options and Genetic Screening of a Patient With Moyamoya Disease Harboring the
Nomura S; Akagawa H; Yamaguchi K; Kawashima A; Kawamata T
J Child Neurol; 2020 Aug; 35(9):621-622. PubMed ID: 32212963
[No Abstract] [Full Text] [Related]
17. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
18. Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.
Hadisurya J; Guey S; Grangeon L; Wieczorek D; Corpechot M; Schwitalla JC; Kraemer M
Childs Nerv Syst; 2019 Jul; 35(7):1231-1237. PubMed ID: 31037424
[TBL] [Abstract][Full Text] [Related]
19. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFκB activation and apoptosis in an AAA+ domain-dependent manner.
Takeda M; Tezuka T; Kim M; Choi J; Oichi Y; Kobayashi H; Harada KH; Mizushima T; Taketani S; Koizumi A; Youssefian S
Biochem Biophys Res Commun; 2020 May; 525(3):668-674. PubMed ID: 32139119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
